{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:15:49Z","timestamp":1759936549214},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s10165-011-0556-y","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T23:44:32Z","timestamp":1321487072000},"page":"584-588","source":"Crossref","is-referenced-by-count":8,"title":["High serum matrix metalloproteinase 3 is characteristic of patients with paraneoplastic remitting seronegative symmetrical synovitis with pitting edema syndrome"],"prefix":"10.1093","volume":"22","author":[{"given":"Tomoki","family":"Origuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ya","family":"Kawashiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tsukada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Aramaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Furuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichiro","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yojiro","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Iwanaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Terada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitaka","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,11,17]]},"reference":[{"key":"556_CR1","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.1985.03360190069027","volume":"254","author":"DJ McCarty","year":"1985","unstructured":"McCarty DJ, O\u2019Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. JAMA. 1985;254:2763\u20137.","journal-title":"JAMA"},{"key":"556_CR2","first-page":"633","volume":"17","author":"EB Russell","year":"1990","unstructured":"Russell EB, Hunter JB, Pearson L, McCarty DJ. Remitting seronegative symmetrical synovitis with pitting edema. Thirteen additional cases. J Rheumatol. 1990;17:633\u20139.","journal-title":"J Rheumatol"},{"key":"556_CR3","first-page":"115","volume":"26","author":"J Sibilia","year":"1999","unstructured":"Sibilia J, Friess S, Schaeverbeke T, Maloisel F, Bertin P, Goichot B, et al. Remitting seronegative synovitis with pitting edema (RS3PE): a form of paraneoplastic polyarthritis? J Rheumatol. 1999;26:115\u201320.","journal-title":"J Rheumatol"},{"key":"556_CR4","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1136\/ard.2004.032995","volume":"64","author":"K Arima","year":"2005","unstructured":"Arima K, Origuchi T, Tamai M, Iwanaga N, Izumi Y, Huang M, et al. RS3PE syndrome presenting as vascular endothelial growth factor associated disorder. Ann Rheum Dis. 2005;64:1653\u20134.","journal-title":"Ann Rheum Dis"},{"key":"556_CR5","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s00296-009-1142-x","volume":"30","author":"S Kawashiri","year":"2010","unstructured":"Kawashiri S, Nakano M, Kawakami A, Eguchi K. Monitoring of therapeutic efficacy in a patient with RS3PE syndrome by serologic variables and radiographic methods. Rheumatol Int. 2010;30:1677\u201380.","journal-title":"Rheumatol Int"},{"key":"556_CR6","first-page":"234","volume":"24","author":"SE Tunc","year":"2004","unstructured":"Tunc SE, Arshan C, Bayram N, Sahin M, Akkus S, Yorgancigil H. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome): a report of two cases and review of the literature. Rheumatol Int. 2004;24:234\u20137.","journal-title":"Rheumatol Int"},{"key":"556_CR7","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1007\/s10620-009-0926-x","volume":"55","author":"Y Yeh","year":"2010","unstructured":"Yeh Y, Sheu B, Cheng H, Wang YL, Yang HB, Wu JJ. Elevated serum matrix metalloproteinase-3 and -7 in H. pylori-related gastric cancer can be biomarkers correlating with a poor survival. Dig Dis Sci. 2010;55:1649\u201357.","journal-title":"Dig Dis Sci"},{"key":"556_CR8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0009-8981(92)90105-Y","volume":"211","author":"K Obata","year":"1992","unstructured":"Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta. 1992;211:59\u201372.","journal-title":"Clin Chim Acta"},{"key":"556_CR9","first-page":"333","volume":"24","author":"A Olive","year":"1997","unstructured":"Olive A, del Blanco J, Pons M, Vaquero M, Tena X. The clinical spectrum of remitting seronegative symmetrical synovitis with pitting edema. J Rheumatol. 1997;24:333\u20136.","journal-title":"J Rheumatol"},{"key":"556_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00296-003-0330-3","volume":"24","author":"R Queiro","year":"2004","unstructured":"Queiro R. RS3PE syndrome: a clinical and immunological study. Rheumatol Int. 2004;24:103\u20135.","journal-title":"Rheumatol Int"},{"key":"556_CR11","first-page":"741","volume":"17","author":"F Cantini","year":"1999","unstructured":"Cantini F, Salvarani C, Olivieri I. Paraneoplastic remitting seronegative symmetrical synovitis with pitting edema. Exp Rheumatol. 1999;17:741\u20134.","journal-title":"Exp Rheumatol"},{"key":"556_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/ard.61.2.161","volume":"61","author":"C Ribbens","year":"2002","unstructured":"Ribbens C, Martin y Porras M, Franchimont N, Kaiser MJ, Jaspar JM, Damas P, et al. Increased matrix metalloproteinase-3 serum levels in rheumatic diseases: relationship with synovitis and steroid treatment. Ann Rheum Dis. 2002;61:161\u20136.","journal-title":"Ann Rheum Dis"},{"key":"556_CR13","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1158\/1078-0432.CCR-04-0424","volume":"10","author":"S Curran","year":"2004","unstructured":"Curran S, Dundas SR, Buxton J, Leeman MF, Ramsay R, Murray GI. Matrix metalloproteinase\/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res. 2004;10:8229\u201334.","journal-title":"Clin Cancer Res"},{"key":"556_CR14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1023\/A:1025867130437","volume":"23","author":"S Zucker","year":"2004","unstructured":"Zucker S, Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev. 2004;23:101\u201317.","journal-title":"Cancer Metastasis Rev"},{"key":"556_CR15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/jsre.2000.5952","volume":"93","author":"K Inuzuka","year":"2000","unstructured":"Inuzuka K, Ogata Y, Nagase H, Shirouzu K. Significance of coexpression of urokinase-type plasminogen activator, and matrix metalloproteinase 3 (stromelysin) and 9 (gelatinase B) in colorectal carcinoma. J Surg Res. 2000;93:211\u20138.","journal-title":"J Surg Res"},{"key":"556_CR16","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1002\/(SICI)1097-0142(19961201)78:11<2379::AID-CNCR17>3.0.CO;2-Y","volume":"78","author":"K Gohji","year":"1996","unstructured":"Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Kamidono S, et al. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer. 1996;78:2379\u201387.","journal-title":"Cancer"},{"key":"556_CR17","first-page":"2055","volume":"57","author":"H Ueno","year":"1997","unstructured":"Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, et al. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res. 1997;57:2055\u201360.","journal-title":"Cancer Res"},{"key":"556_CR18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1034\/j.1600-0625.2003.120201.x","volume":"12","author":"E Kerkel\u00e4","year":"2003","unstructured":"Kerkel\u00e4 E, Saarialho-Kere U. Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer. Exp Dermatol. 2003;12:109\u201325.","journal-title":"Exp Dermatol"},{"key":"556_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0049-0172(99)80037-7","volume":"29","author":"JE Naschitz","year":"1999","unstructured":"Naschitz JE, Rosner I, Rozenbaum M, Zuckerman E, Yeshurun D. Rheumatic syndromes: clues to occult neoplasia. Semin Arthritis Rheum. 1999;29:43\u201355.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-011-0556-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:25:41Z","timestamp":1646843141000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-011-0556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,17]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1007\/s10165-011-0556-y","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,17]]}}}